nightsurfer | Shared With: Everyone - Apr 08 2007 | brain, cancer, malignant, human, glioma, cells, glioblastoma, VEGF, anti-cancer, compound, Nordy, inhibits, CXCR4, nordihydroguaiaretic, acid, angiogenesis, metastasis, anti-angiogenic, inhibition, inhibitor, inhibitors, medicine, medline, study, science, research, peer-reviewed, p, imported:del.icio.usPing YF, Yao XH, Chen JH, Liu H, Chen DL, Zhou XD, Wang JM, Bian XW. The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells.J Neurooncol. 2007 Apr 6; [Epub ahead of print]PMID: 17415525 [Pu
nightsurfer | Shared With: Everyone - Apr 08 2007 | TGF-beta, inhibitors, inhibition, inhibitor, cancer, news, control, management, anti-cancer, agent, metastases, metastasis, prevent, prevention, treatment, therapy, imported:del.icio.usFor several types of cancer, persistently high levels of the soluble factor TGF-beta in the blood after surgery, chemotherapy, or radiation therapy correlate with increased risk of early metastasis and a poor prognosis. Using a mouse model of breast cance
nightsurfer | Shared With: Everyone - Apr 07 2007 | anti-angiogenic, anti-angiogenesis, anti-copper, angiogenesis, Tetrathiomolybdate, Doxorubicin, Breast, Carcinoma, cancer, breastcancer, chemotherapy, agent, inhibition, inhibitor, inhibitors, copper, reduction, science, study, research, medicine, medline, peer-reviewed, imported:del.icio.usPan Q, Bao LW, Kleer CG, Brewer GJ, Merajver SD. Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma.Mol Cancer Ther. 2003 Jul;2(7):617-22.PMID: 12883034 [PubMed - indexed for MEDLINE]
nightsurfer | Shared With: Everyone - Apr 07 2007 | Inhibition, Growth, Squamous, Cell, Carcinoma, Tetrathiomolybdate, Copper, Suppression, cancer, anti-angiogenesis, anti-angiogenic, anti-copper, agent, angiogenesis, inhibitor, inhibitors, reduction, head, headandneck, hnscc, neck, scc, medicine, medline, science, study, research, imported:del.icio.usC. Cox, S. D. Merajver, S. Yoo, R. D. Dick, G. J. Brewer, J. S.-J. Lee, and T. N. TeknosInhibition of the Growth of Squamous Cell Carcinoma byTetrathiomolybdate-Induced Copper Suppression in a Murine ModelArch Otolaryngol Head Neck Surg, July 1, 200
nightsurfer | Shared With: Everyone - Apr 07 2007 | Phase-II, phaseII, Trial, Tetrathiomolybdate, Advanced, Kidney, Cancer, renal, kidneycancer, clinicaltrial, anti-angiogenesis, anti-angiogenic, anti-copper, agent, angiogenesis, copper, inhibition, inhibitor, inhibitors, reduction, medicine, medline, oncology, science, study, res, imported:del.icio.usB. G. Redman, P. Esper, Q. Pan, R. L. Dunn, H. K. Hussain, T. Chenevert, G. J. Brewer, and S. D. MerajverPhase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney CancerClin. Cancer Res., May 1, 2003; 9(5): 1666 - 1672.
nightsurfer | Shared With: Everyone - Apr 07 2007 | Cancer, Therapy, Tetrathiomolybdate, anti-angiogenesis, anti-angiogenic, anti-copper, agent, angiogenesis, Copper, Review, reduction, inhibition, inhibitor, inhibitors, treatment, science, study, medicine, medline, peer-reviewed, oncology, imported:del.icio.usBrewer GJ, Merajver SD. Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review.Integr Cancer Ther. 2002 Dec;1(4):327-37. Review.PMID: 14664727 [PubMed - indexed for MEDLINE]
nightsurfer | Shared With: Everyone - Apr 07 2007 | Copper, Deficiency, Tetrathiomolybdate, Suppresses, Tumor, cancer, Growth, Angiogenesis, anti-copper, anti-angiogenesis, anti-angiogenic, agent, inhibition, inhibitor, inhibitors, medicine, medline, oncology, science, study, research, peer-reviewed, treatment, therapy, imported:del.icio.usQ. Pan, C. G. Kleer, K. L. van Golen, J. Irani, K. M. Bottema, C. Bias, M. De Carvalho, E. A. Mesri, D. M. Robins, R. D. Dick, G. J. Brewer, and S. D. MerajverCopper Deficiency Induced by Tetrathiomolybdate Suppresses Tumor Growth and AngiogenesisCanc
nightsurfer | Shared With: Everyone - Apr 07 2007 | angiogenesis, Cancer, Control, Therapeutic, Trial, inhibition, inhibitor, inhibitors, medicine, oncology, treatment, therapy, anti-angiogenesis, anti-angiogenic, imported:del.icio.us
nightsurfer | Shared With: Everyone - Apr 07 2007 | Tetrathiomolybdate, Cancer, Protocol, Treatment, Management, therapy, anti-angiogenic, anti-copper, agent, angiogenesis, inhibition, inhibitor, inhibitors, info, information, copper, reduction, medicine, oncology, imported:del.icio.usIf angiogenesis controls cancer growth, what controls angiogenesis? Researchers at the University of Michigan and the University of South Florida believe that the copper status is critical to the function growth factors.
nightsurfer | Shared With: Everyone - Apr 07 2007 | Tetrathiomolybdate, Compounding, Pharmacy, cancer, anti-angiogenic, anti-copper, agent, angiogenesis, inhibition, inhibitor, inhibitors, copper, reduction, info, information, imported:del.icio.usAt our pharmacy, we have compounded Ammonium Tetrathiomolybdate Capsules for several cancer patients. The results in many of these patients have been encouraging. Ammonium Tetrathiomolybdate Capsules are a prescription medication.
Related Content from Around Faves
cancer
-
Randy Pausch finally succumbed to pancreatic cancer. If you missed the video of his lecture, you can catch it here:
http://www.youtube.com/watch?v=ji5_MqicxSo
2 FaversViewed: 3 TimesQuoted: "But we don't beat the Reaper by living longer. We beat the Reaper by living well," said Dr. Pausch, who urged the graduates to find ...
- cltg3006 - 29 days ago1 FaverViewed: 6 Times
- rthfutio - Jul 21 200811 Favers
